Sensus Healthcare Inc (STU:5TX)

Q4 2025 Sensus Healthcare Inc Earnings Call Transcript

Feb 12, 2026 / 09:30 PM GMT

Release Date Price: €3.9 (-1.52%)

Transcript 8-K

Key Points

Positve

Sensus Healthcare Inc (SRTS) has been awarded exclusive CPT codes for its SRT technology, providing clear reimbursement for treating non-melanoma skin cancer.
The company starts 2026 with $22 million in cash, zero debt, and plans to expand its sales force.
International demand is strong, with shipments to China and other countries, contributing to margin benefits.
The company expects first-quarter system shipments to exceed fourth-quarter levels, even without contributions from its largest customer.
Sensus Healthcare Inc (SRTS) aims for full-year profitability in 2026, with a more diversified customer base and expanding international opportunities.

Negative

Revenues for the fourth quarter of 2025 were significantly lower at $4.9 million compared to $31 million in the fourth quarter of 2024.
The company experienced a net loss of $3.2 million for the fourth quarter of 2025, compared to a net income of $1.5 million in the same period of 2024.
Gross profit margins decreased to 38.8% in the fourth quarter of 2025 from 54.2% in the fourth quarter of 2024.
General and administrative expenses increased for the full year 2025, primarily due to higher professional fees and compensation costs.
Research and development expenses rose significantly in 2025, driven by costs related to reimbursement efforts and product development.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SRTS.OQ - Sensus Healthcare Inc
Q4 2025 Sensus Healthcare Inc Earnings Call
Feb 12, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the Census Healthcare Fourth quarter and full year 2025 financial results conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing, then 0 on your telephone keypad. After today's presentation, there will be Opportunity to ask questions. To ask a question, you may press 1 on your telephone keypad. To withdraw your question, please press 2.

Please note this event is being recorded. I would now like to turn the conference over to Turth Patel with Alliance Advisors IR. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.